• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国严重脓毒症发病率和死亡率的基准研究。

Benchmarking the incidence and mortality of severe sepsis in the United States.

机构信息

Department of Emergency Medicine, University of Pennsylvania, Philadelphia, PA, USA.

出版信息

Crit Care Med. 2013 May;41(5):1167-74. doi: 10.1097/CCM.0b013e31827c09f8.

DOI:10.1097/CCM.0b013e31827c09f8
PMID:23442987
Abstract

BACKGROUND

In 1992, the first consensus definition of severe sepsis was published. Subsequent epidemiologic estimates were collected using administrative data, but ongoing discrepancies in the definition of severe sepsis produced large differences in estimates.

OBJECTIVES

We seek to describe the variations in incidence and mortality of severe sepsis in the United States using four methods of database abstraction. We hypothesized that different methodologies of capturing cases of severe sepsis would result in disparate estimates of incidence and mortality.

DESIGN, SETTING, PARTICIPANTS: Using a nationally representative sample, four previously published methods (Angus et al, Martin et al, Dombrovskiy et al, and Wang et al) were used to gather cases of severe sepsis over a 6-year period (2004-2009). In addition, the use of new International Statistical Classification of Diseases, 9th Edition (ICD-9), sepsis codes was compared with previous methods.

MEASUREMENTS

Annual national incidence and in-hospital mortality of severe sepsis.

RESULTS

The average annual incidence varied by as much as 3.5-fold depending on method used and ranged from 894,013 (300/100,000 population) to 3,110,630 (1,031/100,000) using the methods of Dombrovskiy et al and Wang et al, respectively. Average annual increase in the incidence of severe sepsis was similar (13.0% to 13.3%) across all methods. In-hospital mortality ranged from 14.7% to 29.9% using abstraction methods of Wang et al and Dombrovskiy et al. Using all methods, there was a decrease in in-hospital mortality across the 6-year period (35.2% to 25.6% [Dombrovskiy et al] and 17.8% to 12.1% [Wang et al]). Use of ICD-9 sepsis codes more than doubled over the 6-year period (158,722 - 489,632 [995.92 severe sepsis], 131,719 - 303,615 [785.52 septic shock]).

CONCLUSION

There is substantial variability in incidence and mortality of severe sepsis depending on the method of database abstraction used. A uniform, consistent method is needed for use in national registries to facilitate accurate assessment of clinical interventions and outcome comparisons between hospitals and regions.

摘要

背景

1992 年,首次发布了严重脓毒症的共识定义。随后,使用行政数据收集了流行病学估计值,但严重脓毒症的定义持续存在差异,导致估计值存在很大差异。

目的

我们旨在使用四种数据库提取方法描述美国严重脓毒症的发病率和死亡率的变化。我们假设,严重脓毒症病例的不同采集方法将导致发病率和死亡率的估计值存在显著差异。

设计、地点、参与者:使用全国代表性样本,采用四种先前发表的方法(Angus 等人、Martin 等人、Dombrovskiy 等人和 Wang 等人),在 6 年期间(2004-2009 年)收集严重脓毒症病例。此外,还比较了新的国际疾病分类,第 9 版(ICD-9)败血症编码与先前的方法。

测量

严重脓毒症的年度全国发病率和院内死亡率。

结果

根据所使用的方法,平均年发病率差异高达 3.5 倍,使用 Dombrovskiy 等人和 Wang 等人的方法,发病率分别为 300/100,000 人口(894,013 例)和 1,031/100,000 人口(3,110,630 例)。所有方法的严重脓毒症发病率平均年增长率相似(13.0%至 13.3%)。使用 Wang 等人和 Dombrovskiy 等人的提取方法,院内死亡率在 14.7%至 29.9%之间。使用所有方法,6 年期间院内死亡率呈下降趋势(Dombrovskiy 等人的 35.2%至 25.6%和 Wang 等人的 17.8%至 12.1%)。6 年内,ICD-9 败血症编码的使用量增加了一倍多(158,722 至 489,632 [995.92 例严重脓毒症],131,719 至 303,615 [785.52 例感染性休克])。

结论

严重脓毒症的发病率和死亡率因数据库提取方法的不同而存在很大差异。需要使用一种统一、一致的方法用于国家登记,以促进对临床干预措施的准确评估以及医院和地区之间的结果比较。

相似文献

1
Benchmarking the incidence and mortality of severe sepsis in the United States.美国严重脓毒症发病率和死亡率的基准研究。
Crit Care Med. 2013 May;41(5):1167-74. doi: 10.1097/CCM.0b013e31827c09f8.
2
The outcome of patients with sepsis and septic shock presenting to emergency departments in Australia and New Zealand.在澳大利亚和新西兰的急诊科就诊的脓毒症和脓毒性休克患者的治疗结果。
Crit Care Resusc. 2007 Mar;9(1):8-18.
3
Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care.患有严重脓毒症的住院癌症患者:发病率、死亡率及相关护理成本分析
Crit Care. 2004 Oct;8(5):R291-8. doi: 10.1186/cc2893. Epub 2004 Jul 5.
4
The use of impedance cardiography in predicting mortality in emergency department patients with severe sepsis and septic shock.阻抗心动描记术在预测急诊科严重脓毒症和脓毒性休克患者死亡率中的应用。
Acad Emerg Med. 2010 Apr;17(4):452-5. doi: 10.1111/j.1553-2712.2010.00705.x.
5
Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock.血清乳酸水平与严重脓毒症患者的死亡率相关,且独立于器官功能衰竭和休克。
Crit Care Med. 2009 May;37(5):1670-7. doi: 10.1097/CCM.0b013e31819fcf68.
6
Outcomes associated with conventional management of severe sepsis at Damas Hospital.大马士革医院严重脓毒症传统治疗的相关结果。
Bol Asoc Med P R. 2011 Apr-Jun;103(2):35-8.
7
Effects of nitroglycerin on sublingual microcirculatory blood flow in patients with severe sepsis/septic shock after a strict resuscitation protocol: a double-blind randomized placebo controlled trial.硝酸甘油对严格复苏方案后严重脓毒症/脓毒性休克患者舌下微循环血流的影响:一项双盲随机安慰剂对照试验。
Crit Care Med. 2010 Jan;38(1):93-100. doi: 10.1097/CCM.0b013e3181b02fc1.
8
Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland.英格兰、威尔士和北爱尔兰重症监护病房中发生在最初24小时内的严重脓毒症的流行病学情况。
Crit Care Med. 2003 Sep;31(9):2332-8. doi: 10.1097/01.CCM.0000085141.75513.2B.
9
Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis*.20 年来严重脓毒症患者死亡率趋势:一项比较性荟萃分析*。
Crit Care Med. 2014 Mar;42(3):625-31. doi: 10.1097/CCM.0000000000000026.
10
The sepsis six and the severe sepsis resuscitation bundle: a prospective observational cohort study.脓毒症 6 小时集束化治疗和严重脓毒症复苏集束化治疗:一项前瞻性观察性队列研究。
Emerg Med J. 2011 Jun;28(6):507-12. doi: 10.1136/emj.2010.095067. Epub 2010 Oct 29.

引用本文的文献

1
Effects of different vitamins on individuals with septic shock: a Bayesian NMA of RCTs.不同维生素对感染性休克患者的影响:随机对照试验的贝叶斯网络Meta分析
Front Nutr. 2025 Aug 13;12:1566422. doi: 10.3389/fnut.2025.1566422. eCollection 2025.
2
Association Between Traditional Chinese Medicine Use and Sepsis Risk and Glucocorticoid Exposure in Patients With Systemic Lupus Erythematosus: A Retrospective Cohort Study.系统性红斑狼疮患者使用中药与脓毒症风险及糖皮质激素暴露之间的关联:一项回顾性队列研究
Int J Rheum Dis. 2025 Aug;28(8):e70403. doi: 10.1111/1756-185x.70403.
3
Machine learning based screening of biomarkers associated with cell death and immunosuppression of multiple life stages sepsis populations.
基于机器学习对与多生命阶段脓毒症人群细胞死亡和免疫抑制相关生物标志物的筛选。
Sci Rep. 2025 Aug 19;15(1):30302. doi: 10.1038/s41598-025-14600-0.
4
[S3 guideline on sepsis-prevention, diagnosis, therapy, and follow-up care-update 2025].[S3 脓毒症预防、诊断、治疗及随访指南 - 2025年更新版]
Med Klin Intensivmed Notfmed. 2025 Aug 18. doi: 10.1007/s00063-025-01317-1.
5
Unraveling NETs in Sepsis: From Cellular Mechanisms to Clinical Relevance.解析脓毒症中的中性粒细胞胞外陷阱:从细胞机制到临床意义
Int J Mol Sci. 2025 Aug 1;26(15):7464. doi: 10.3390/ijms26157464.
6
Stress granule component TIA-1 is a negative regulator of the non-canonical NLRP3 inflammasome.应激颗粒成分TIA-1是非经典NLRP3炎性小体的负调节因子。
bioRxiv. 2025 Jul 16:2025.07.12.634801. doi: 10.1101/2025.07.12.634801.
7
Patterns of left and right ventricular dysfunction and their clinical outcomes in septic patients.脓毒症患者左、右心室功能障碍模式及其临床结局
BMC Anesthesiol. 2025 Jul 29;25(1):364. doi: 10.1186/s12871-025-03233-5.
8
AI-driven discovery of minimal sepsis biomarkers for disease detection and progression: precision medicine across diverse populations.人工智能驱动发现用于疾病检测和进展的最小化脓毒症生物标志物:针对不同人群的精准医学。
Front Med (Lausanne). 2025 Jul 1;12:1521827. doi: 10.3389/fmed.2025.1521827. eCollection 2025.
9
Development and validation of a predictive model for invasive ventilation risk within 48 hours of admission in patients with early sepsis-associated acute kidney injury.早期脓毒症相关性急性肾损伤患者入院48小时内有创通气风险预测模型的开发与验证
Front Med (Lausanne). 2025 Jun 18;12:1577154. doi: 10.3389/fmed.2025.1577154. eCollection 2025.
10
Explainable machine learning models for mortality prediction in patients with sepsis in tertiary care hospital ICU in low- to middle-income countries.低收入和中等收入国家三级护理医院重症监护病房中用于脓毒症患者死亡率预测的可解释机器学习模型。
Intensive Care Med Exp. 2025 Jun 3;13(1):56. doi: 10.1186/s40635-025-00765-5.